about
Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in RatsThe novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humansPharmacokinetics of tramadol after subcutaneous administration in a critically ill population and in a healthy cohort.Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicinDevelopment and application of an analytical method for curdione quantification in pregnant Sprague-Dawley rats by LC-MS/MS.A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours.Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal miceParsing interindividual drug variability: an emerging role for systems pharmacology.Work Capacity of the Bladder During Voiding: A Novel Method to Evaluate Bladder Contractile Function and Bladder Outlet Obstruction.Reversal of Acute Kidney Injury-Induced Neutrophil Dysfunction: A Critical Role for Resistin.Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men.Pharmacokinetics of intravenous lithium chloride and assessment of agreement between two methods of lithium concentration measurement in the horse.Synthesis, preclinical, and pharmacokinetic evaluation of a new zoledronate derivative as a promising antiosteoporotic candidate using radiolabeling technique.gPKPDSim: a SimBiology®-based GUI application for PKPD modeling in drug development.Toxicokinetics of the neonicotinoid insecticide imidacloprid in rainbow trout (Oncorhynchus mykiss).Pharmacokinetics of tildipirosin in beagle dogs.LC-coupled ESI MS for quantification of miltefosine in human and hamster plasma.A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia.Thalidomide pharmacokinetics in sheep.Regional intravenous limb perfusion compared to systemic intravenous administration for marimastat delivery to equine lamellar tissue.Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).Assessment of Liver Function Using Pharmacokinetic Parameters of Gd-EOB-DTPA: Experimental Study in Rat Hepatectomy Model.Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice.Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.
P2860
Q28388038-F2BB2657-128D-4D0F-91D2-9F4DD8BE62C9Q33596716-9DE93D80-8BED-4476-BDEC-90C5B5942B41Q33726256-58CDF250-6F2C-4556-97E4-D4D8CF6B1DDCQ34205189-6DC8C368-281B-4D1A-9652-8BCE856E0CABQ35571011-BD52595C-E5F7-4613-9F0D-854EC41E9E1EQ35677661-2CA82D83-940C-46E1-A192-5FC2B6328121Q36054705-EA0D7964-27F7-4D30-814D-07B47995B14DQ36126322-DAA0E103-F841-4A43-8A9A-92AB09D5B032Q36417380-C943076D-E470-4860-A645-49BA960EF459Q36701631-BF7ECAB1-071E-4F22-8975-0820F4FCC629Q36978604-AD5EF8CB-3199-40BE-960C-E715021F26B9Q37426165-F5C0E68C-C960-4B27-AB1B-223DAE71B5F0Q37550693-C2CE29D0-DA74-488F-A071-663045C5448AQ38459977-A4B230D5-A5C0-4C42-825A-B54438D40549Q39816020-9D550AA2-89A5-43BA-B566-D1D86B694071Q46266811-63A174C1-F00F-40C5-93B1-74D9ABC39C26Q46396656-CF99B2D2-3E18-4C14-8722-ACEEB9458BECQ47207054-39633213-D4C5-4033-92E0-4FAF426E5007Q47697189-D07CD9AD-CEB8-46D5-9DDC-3A36D2B1DAFBQ48003917-B18590F1-EDA0-4387-997A-A085AC317A83Q51738993-343AEC31-C4F8-4146-AF97-F542F8B703ECQ53043418-4991D76B-208B-42AC-AA24-A254B31CB22CQ53225672-51495202-DF9A-41C8-BF1D-6AA41F674A4AQ53622549-E2C37F32-E3B3-4958-B0FF-7A2D9009BA85Q55221178-EA4D00CF-40CE-4109-A102-02A55599E7ADQ55265529-F56AEF9E-1F9E-4962-9686-E4C63FFC52F6Q55385806-DBD2A5A7-6280-48BD-8FD3-C5A11F9A60D9Q55392210-637E8AD2-24D8-4631-A4F4-7235E8052AAD
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Non-compartmental analysis.
@en
Non-compartmental analysis.
@nl
type
label
Non-compartmental analysis.
@en
Non-compartmental analysis.
@nl
prefLabel
Non-compartmental analysis.
@en
Non-compartmental analysis.
@nl
P1476
Non-compartmental analysis.
@en
P2093
Daniel Weiner
Johan Gabrielsson
P304
P356
10.1007/978-1-62703-050-2_16
P407
P577
2012-01-01T00:00:00Z